IMC-Chicago »

Catalyst Pharmaceutical Partners shares owned by IMC-Chicago

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by IMC-Chicago from 13F filings

Historical chart of IMC-Chicago investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by IMC-Chicago consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by IMC-Chicago

Quarter filed Position value Share count Share price at filing
2026-03-31 $14M 564k 24.76

More positions owned by IMC-Chicago

State Str Spdr S&p 500 Etf T Tr Unit Put Option
State Str Spdr S&p 500 Etf T Tr Unit Call Option
Invesco Qqq Tr Unit Ser 1 Put Option
Invesco Qqq Tr Unit Ser 1 Call Option
Nvidia Corp option Call Option
Tesla Motors Inc cmn Call Option
Nvidia Corp option Put Option
Microsoft Corp Call Option
Tesla Motors Inc cmn Put Option
Meta Platforms Cl A Call Option
Apple Inc option Call Option
Meta Platforms Cl A Put Option
Micron Technology Inc call Call Option
Amazon Com Inc option Call Option
Alphabet Cap Stk Cl A Call Option

View all positions for IMC-Chicago

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Vanguard Capital Management
Deerfield Management Company
Dimensional Fund Advisors
Fundsmith
Bank of America Corporation
American Century Companies
Geode Capital Management
Morgan Stanley
Renaissance Technologies
Vanguard Portfolio Management
Royce & Associates
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners